AI assistant
Sending…
PMV Pharmaceuticals, Inc. — Director's Dealing 2025
Jul 3, 2025
34350_dirs_2025-07-03_a5d8d40b-567e-4103-ab26-26c664aaa01a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PMV Pharmaceuticals, Inc. (PMVP)
CIK: 0001699382
Period of Report: 2025-07-01
Reporting Person: Jalota Deepika (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-07-01 | Common Stock | S | 33065 | $1.0645 | Disposed | 89959 | Direct |
Footnotes
F1: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.
More from PMV Pharmaceuticals, Inc.
Interim / Quarterly Report
2026
May 12
Earnings Release
2026
May 12
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 9
Interim / Quarterly Report
2025
Nov 12
Regulatory Filings
2025
Nov 12
Major Shareholding Notification
2025
Nov 12
Director's Dealing
2025
Oct 29